A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children

NCT00760825 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Vibrio Cholerae

Interventions

BIOLOGICAL: killed bivalent (O1 and O139)whole cell oral cholera vaccine

Sponsor

International Vaccine Institute

Collaborators

[object Object]
[object Object]